MEDICLIN AG/ DE0006595101 /
| 2024-04-18 11:56:53 AM | Chg. -0.060 | Volume | Bid1:17:19 PM | Ask1:18:08 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2.600EUR | -2.26% | 2,273 Turnover: 6,115.100 |
2.600Bid Size: 3,160 | 2.780Ask Size: 1,170 | 121.6 mill.EUR | 0.00% | 85.33 |
Assets
| 2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 161.6000 | 158.6000 | 155.5000 | 161.2000 | 161.6000 | ||||||
| Intangible Assets | 1.6000 | 1.6000 | 2 | 1.9000 | 3.6000 | ||||||
| Long-Term Investments | 1.6000 | 2.1000 | 1.5000 | 1.4000 | 1.2000 | ||||||
| Fixed Assets | 222.3000 | 221.1000 | 216.8000 | 217.4000 | 219.3000 | ||||||
| Inventories | 7.1000 | 6.5000 | 6.4000 | 6.2000 | 6.3000 | ||||||
| Accounts Receivable | 59.8000 | 61.4000 | 62 | 67.3000 | 71.1000 | ||||||
| Cash and Cash Equivalents | 22.9000 | 13.2000 | 26.3000 | 29.5000 | 41.6000 | ||||||
| Current Assets | 97.3000 | 91.7000 | 102.8000 | 112 | 127.7000 | ||||||
| Total Assets | 319.6000 | 312.9000 | 319.6000 | 329.4000 | 347.1000 | ||||||
Liabilities
| 2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 17.3000 | 18.2000 | 13 | 12 | 13 | ||||||
| Long-term debt | 67 | 60.5000 | 54.1000 | 47.4000 | 45.5000 | ||||||
| Liabilities to Banks | 75.9000 | 67.6000 | 61.2000 | 65.9000 | 65.2000 | ||||||
| Provisions | 48.1000 | 53.2000 | 64.5000 | 65 | 69 | ||||||
| Liabilities | 162.6000 | 160.7000 | 165.7000 | 160.3000 | 165.5000 | ||||||
| Share Capital | 47.5000 | 47.5000 | 47.5000 | 47.5000 | 47.5000 | ||||||
| Total Equity | 157 | 152.2000 | 153.9000 | 169.1000 | 181.6000 | ||||||
| Minority Interests | -.1000 | -.2000 | -.4000 | -.3000 | -.3000 | ||||||
| Total liabilities equity | 319.6000 | 312.9000 | 319.6000 | 329.4000 | 347.1000 | ||||||
Income Statement
| 2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 509.7000 | 515 | 538 | 555.3000 | 580.3000 | ||||||
| Depreciation (total) | 17.3000 | 17.5000 | 18.5000 | 18.4000 | 19.2000 | ||||||
| Operating Result | 4.3000 | 2.1000 | 15.6000 | 23.6000 | 24 | ||||||
| Interest Income | -5 | -4.7000 | -3.8600 | -3.6100 | -3.1000 | ||||||
| Income Before Taxes | -.8000 | -2.6000 | 11.7000 | 20 | 20.9000 | ||||||
| Income Taxes | .7000 | .2000 | 3.3000 | 3.4000 | 4.3000 | ||||||
| Minority Interests Profit | .1000 | .1000 | .1000 | -.0600 | -.0600 | ||||||
| Net Income | -1.4000 | -2.6000 | 8.5000 | 16.5000 | 16.5000 | ||||||
Per Share
Cash Flow
| 2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 16.2000 | 10 | 32.1000 | 28.9000 | 29.9000 | ||||||
| Cash Flow from Investing Activities | -20.4000 | -11.5000 | -12.5000 | -19 | -17.9000 | ||||||
| Cash Flow from Financing | -14.2000 | -8.2000 | -6.5000 | -6.7000 | .1000 | ||||||
| Decrease / Increase in Cash | -18.4000 | -9.7000 | 13.1000 | 3.2000 | 12.1000 | ||||||
| Employees | 6,256 | 6,372 | 6,432 | 6,524 | 6,649 | ||||||
